473 related articles for article (PubMed ID: 36380021)
1. Death by TNF: a road to inflammation.
van Loo G; Bertrand MJM
Nat Rev Immunol; 2023 May; 23(5):289-303. PubMed ID: 36380021
[TBL] [Abstract][Full Text] [Related]
2. Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy.
Fujisawa S; Konnai S; Okagawa T; Maekawa N; Tanaka A; Suzuki Y; Murata S; Ohashi K
BMC Vet Res; 2019 Feb; 15(1):68. PubMed ID: 30819151
[TBL] [Abstract][Full Text] [Related]
3. Biologics beyond TNF-α inhibitors and the effect of targeting the homologues TL1A-DR3 pathway in chronic inflammatory disorders.
Tougaard P; Zervides KA; Skov S; Hansen AK; Pedersen AE
Immunopharmacol Immunotoxicol; 2016; 38(1):29-38. PubMed ID: 26810853
[TBL] [Abstract][Full Text] [Related]
4. TNF in the liver: targeting a central player in inflammation.
Tiegs G; Horst AK
Semin Immunopathol; 2022 Jul; 44(4):445-459. PubMed ID: 35122118
[TBL] [Abstract][Full Text] [Related]
5. IL-37 suppresses the sustained hepatic IFN-γ/TNF-α production and T cell-dependent liver injury.
Feng XX; Chi G; Wang H; Gao Y; Chen Q; Ru YX; Luo ZL; Yan W; Li PY; Liu M; Feng ZH; Tian DA
Int Immunopharmacol; 2019 Apr; 69():184-193. PubMed ID: 30735937
[TBL] [Abstract][Full Text] [Related]
6. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
Cell; 2021 Jan; 184(1):149-168.e17. PubMed ID: 33278357
[TBL] [Abstract][Full Text] [Related]
7. Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.
Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Llurba E; Gris JM
Clin Rev Allergy Immunol; 2017 Aug; 53(1):40-53. PubMed ID: 28054230
[TBL] [Abstract][Full Text] [Related]
8. TNF-α inhibitors with anti-oxidative stress activity from natural products.
Li J; Zhang H; Huang W; Qian H; Li Y
Curr Top Med Chem; 2012; 12(13):1408-21. PubMed ID: 22650374
[TBL] [Abstract][Full Text] [Related]
9. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.
Chiu YM; Chen DY
Expert Rev Clin Immunol; 2020 Feb; 16(2):207-228. PubMed ID: 31852268
[No Abstract] [Full Text] [Related]
10. Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity.
Wang Y; Guo L; Yin X; McCarthy EC; Cheng MI; Hoang AT; Chen HC; Patel AY; Allard Trout D; Xu E; Yakobian N; Hugo W; Howard JF; Sheu KM; Hoffmann A; Lechner MG; Su MA
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35058362
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell apicobasal polarity coordinates distinct responses to luminally versus abluminally delivered TNF-α in a microvascular mimetic.
Salminen AT; Tithof J; Izhiman Y; Masters EA; McCloskey MC; Gaborski TR; Kelley DH; Pietropaoli AP; Waugh RE; McGrath JL
Integr Biol (Camb); 2020 Nov; 12(11):275-289. PubMed ID: 33164044
[TBL] [Abstract][Full Text] [Related]
12. TNF-α: The shape of small molecules to come?
Dömling A; Li X
Drug Discov Today; 2022 Jan; 27(1):3-7. PubMed ID: 34229081
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases.
Zhang N; Wang Z; Zhao Y
Cytokine Growth Factor Rev; 2020 Oct; 55():80-85. PubMed ID: 32327345
[TBL] [Abstract][Full Text] [Related]
14. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
Zaka M; Abbasi BH; Durdagi S
J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
[TBL] [Abstract][Full Text] [Related]
15. The kiss of (cell) death: can venom-induced immune response contribute to dermal necrosis following arthropod envenomations?
Dunbar JP; Sulpice R; Dugon MM
Clin Toxicol (Phila); 2019 Aug; 57(8):677-685. PubMed ID: 30806093
[No Abstract] [Full Text] [Related]
16. Exploring the extensive crosstalk between the antagonistic cytokines- TGF-β and TNF-α in regulating cancer pathogenesis.
Dash S; Sahu AK; Srivastava A; Chowdhury R; Mukherjee S
Cytokine; 2021 Feb; 138():155348. PubMed ID: 33153895
[TBL] [Abstract][Full Text] [Related]
17. Checkpoints in TNF-Induced Cell Death: Implications in Inflammation and Cancer.
Annibaldi A; Meier P
Trends Mol Med; 2018 Jan; 24(1):49-65. PubMed ID: 29217118
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory Cytokine Profile in Crohn's Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy.
Yarur AJ; Jain A; Quintero MA; Czul F; Deshpande AR; Kerman DH; Abreu MT
J Clin Gastroenterol; 2019 Mar; 53(3):210-215. PubMed ID: 29517712
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor (TNF) biology and cell death.
Bertazza L; Mocellin S
Front Biosci; 2008 Jan; 13():2736-43. PubMed ID: 17981749
[TBL] [Abstract][Full Text] [Related]
20. TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases.
Totzke J; Scarneo SA; Yang KW; Haystead TAJ
Open Biol; 2020 Sep; 10(9):200099. PubMed ID: 32873150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
